Body Fat Redistribution Patterns During Perimenopause

Published February 2026 | Educational Resource

Body Composition Changes Beyond Weight

While many discussions of midlife weight changes focus on scale weight, longitudinal research reveals that body composition—the ratio of muscle to fat—undergoes significant shifts even when total weight remains stable. These changes in composition contribute to the metabolic and physiological characteristics of the perimenopausal transition.

Lean Mass Decline

Lean mass includes muscle tissue, bone, organs, and water. Longitudinal studies document that women typically experience lean mass losses of approximately 0.5–1 kg per year during midlife, with acceleration during perimenopause in some studies.

This decline occurs through multiple mechanisms:

• Reduced oestrogen: Oestrogen promotes muscle protein synthesis and inhibits muscle protein breakdown. Declining oestrogen shifts this balance, favoring proteolysis (breakdown).
• Age-related sarcopenia: Natural loss of motor neurons and muscle fibres accelerates with age, particularly in the absence of resistance training.
• Reduced physical activity: Some midlife women reduce activity levels, further accelerating muscle loss.
• Hormonal changes affecting growth hormone and IGF-1: These anabolic hormones also decline with age and hormonal changes, reducing muscle maintenance.

Fat Mass Redistribution

Concurrently with lean mass loss, fat mass distribution shifts. The most notable change is the relative increase in visceral adiposity—fat stored within the abdominal cavity surrounding organs—and corresponding decrease in peripheral (hip, thigh) fat deposition.

Oestrogen normally inhibits visceral fat accumulation. As oestrogen declines, this inhibition is removed. Additionally, research suggests that fat cells themselves become more metabolically active in storing triglycerides in central locations during hormonal transition.

Subcutaneous vs. Visceral Fat

Subcutaneous fat (under the skin) is relatively metabolically inert and storage-focused. Visceral fat is more metabolically active, releasing inflammatory markers and free fatty acids into circulation. These differences have metabolic consequences:

• Visceral fat elevation is associated with greater systemic inflammation
• Visceral fat is more strongly linked to insulin resistance patterns
• Visceral fat directly effects hepatic (liver) metabolism, altering glucose and lipid processing

Body Recomposition Without Weight Change

A critical observation from longitudinal research: body composition can change substantially without significant weight change. For example, if a woman loses 3 kg of muscle and gains 2 kg of fat, her scale weight changes by only 1 kg, yet her body composition has shifted meaningfully.

This phenomenon occurs because muscle and fat have different densities. One kilogram of muscle occupies less volume than one kilogram of fat. Therefore, body recomposition can occur with minimal scale weight changes, yet produce visible changes in body shape and metabolic characteristics.

Bone Mineral Density Changes

Oestrogen is critical for bone density maintenance. During perimenopause and early postmenopause, women experience accelerated bone loss, particularly in trabecular bone. Annual bone loss rates may reach 2–3% in early postmenopause, compared to 1% or less in premenopausal years.

This accelerated loss reflects both the direct oestrogen effects on bone remodelling and the effects on calcium absorption and parathyroid hormone regulation.

Individual Variation

The magnitude of body composition changes varies substantially between individuals, influenced by:

• Genetic predisposition to body composition patterns
• Habitual physical activity, particularly resistance training
• Protein intake adequacy
• Metabolic health markers (insulin sensitivity, inflammation)
• Duration and magnitude of oestrogen decline

Metabolic Consequences of Composition Shifts

These compositional changes have direct metabolic consequences. Loss of metabolically active muscle lowers BMR. Increase in visceral fat raises inflammatory markers and impairs insulin sensitivity. Together, these shifts contribute to the metabolic profile of midlife women.

Summary

Body composition undergoes significant shifts during perimenopause independent of weight change. Lean mass declines while fat mass redistributes toward visceral accumulation. These changes reflect hormonal influences on tissue metabolism and represent observable physiological adaptations to the midlife transition.

Back to Research Articles